Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Early Experience of Macitentan for Pulmonary Arterial Hypertension in Adult Congenital Heart Disease.

Herbert S, Gin-Sing W, Howard L, Tulloh RMR.

Heart Lung Circ. 2017 Oct;26(10):1113-1116. doi: 10.1016/j.hlc.2016.12.011. Epub 2017 Feb 6.

PMID:
28237536
2.

Palliative care in pulmonary arterial hypertension.

Gin-Sing W.

Curr Opin Support Palliat Care. 2017 Mar;11(1):7-11. doi: 10.1097/SPC.0000000000000252. Review.

PMID:
27984330
3.

Practical considerations for therapies targeting the prostacyclin pathway.

Farber HW, Gin-Sing W.

Eur Respir Rev. 2016 Dec;25(142):418-430. doi: 10.1183/16000617.0083-2016. Review.

4.

Exercise physiological responses to drug treatments in chronic thromboembolic pulmonary hypertension.

Charalampopoulos A, Gibbs JS, Davies RJ, Gin-Sing W, Murphy K, Sheares KK, Pepke-Zaba J, Jenkins DP, Howard LS.

J Appl Physiol (1985). 2016 Sep 1;121(3):623-8. doi: 10.1152/japplphysiol.00087.2016. Epub 2016 Jul 14.

5.

Left main bronchus compression due to main pulmonary artery dilatation in pulmonary hypertension: two case reports.

Jaijee SK, Ariff B, Howard L, O'Regan DP, Gin-Sing W, Davies R, Gibbs JS.

Pulm Circ. 2015 Dec;5(4):723-5. doi: 10.1086/683687.

6.

Response to pulmonary arterial hypertension drug therapies in patients with pulmonary arterial hypertension and cardiovascular risk factors.

Charalampopoulos A, Howard LS, Tzoulaki I, Gin-Sing W, Grapsa J, Wilkins MR, Davies RJ, Nihoyannopoulos P, Connolly SB, Gibbs JS.

Pulm Circ. 2014 Dec;4(4):669-78. doi: 10.1086/678512.

7.

Capsaicin 8% patch for treprostinil subcutaneous infusion site pain in pulmonary hypertension patients.

Libri V, Gibbs JS, Pinato DJ, Iddamalgoda T, Khengar RH, Gin-Sing W, Huson L, Anand P.

Br J Anaesth. 2014 Feb;112(2):337-47. doi: 10.1093/bja/aet308. Epub 2013 Sep 22.

8.

Diagnosing and managing pulmonary hypertension.

Charalampopoulos A, Raphael C, Gin-Sing W, Gibbs JS.

Practitioner. 2012 Nov-Dec;256(1756):21-5, 2-3. Review.

PMID:
23477017
9.

Treat-to-target approach in pulmonary arterial hypertension: a consensus-based proposal.

Sitbon O, Baloira Villar A, Bauer F, Ekmehag B, Gin-Sing W, Jansson K, Kiely DG, Leuchte H, Manes A, Rosenkranz S, Escribano P.

Eur Respir Rev. 2012 Sep 1;21(125):259-62. doi: 10.1183/09059180.00003612. No abstract available.

10.

The association of clinical outcome with right atrial and ventricular remodelling in patients with pulmonary arterial hypertension: study with real-time three-dimensional echocardiography.

Grapsa J, Gibbs JS, Cabrita IZ, Watson GF, Pavlopoulos H, Dawson D, Gin-Sing W, Howard LS, Nihoyannopoulos P.

Eur Heart J Cardiovasc Imaging. 2012 Aug;13(8):666-72. doi: 10.1093/ehjci/jes003. Epub 2012 Jan 30.

PMID:
22294683
11.

Pulmonary arterial hypertension: a multidisciplinary approach to care.

Gin-Sing W.

Nurs Stand. 2010 May 26-Jun 1;24(38):40-7.

PMID:
20550084
12.

The responsiveness and validity of the CAMPHOR Utility Index.

Meads DM, McKenna SP, Doughty N, Das C, Gin-Sing W, Langley J, Pepke-Zaba J.

Eur Respir J. 2008 Dec;32(6):1513-9. doi: 10.1183/09031936.00069708. Epub 2008 Sep 3.

13.
14.

Sildenafil versus Endothelin Receptor Antagonist for Pulmonary Hypertension (SERAPH) study.

Wilkins MR, Paul GA, Strange JW, Tunariu N, Gin-Sing W, Banya WA, Westwood MA, Stefanidis A, Ng LL, Pennell DJ, Mohiaddin RH, Nihoyannopoulos P, Gibbs JS.

Am J Respir Crit Care Med. 2005 Jun 1;171(11):1292-7. Epub 2005 Mar 4.

PMID:
15750042

Supplemental Content

Loading ...
Support Center